FingerTango（FGRT.F）株式概要An investment holding company, develops and publishes online mobile games in the People’s Republic of China. 詳細FGRT.F ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析過去5年間で収益は年間59.4%減少しました。 株式の流動性は非常に低い 意味のある時価総額がありません ( $20M )すべてのリスクチェックを見るFGRT.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.01271.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-626m1b2016201920222025202620282031Revenue CN¥415.2mEarnings CN¥53.8mAdvancedSet Fair ValueView all narrativesFingerTango Inc. 競合他社Motorsport GamesSymbol: NasdaqCM:MSGMMarket cap: US$23.7mGigaMediaSymbol: NasdaqCM:GIGMMarket cap: US$16.5mDarkirisSymbol: NasdaqCM:DKIMarket cap: US$7.9mGamehaus HoldingsSymbol: NasdaqCM:GMHSMarket cap: US$50.6m価格と性能株価の高値、安値、推移の概要FingerTango過去の株価現在の株価HK$0.01252週高値HK$0.01252週安値HK$0.012ベータ1.211ヶ月の変化0%3ヶ月変化n/a1年変化-77.55%3年間の変化n/a5年間の変化n/aIPOからの変化-76.32%最新ニュースお知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.お知らせ • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026お知らせ • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.お知らせ • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025お知らせ • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.最新情報をもっと見るRecent updatesお知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.お知らせ • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026お知らせ • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.お知らせ • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025お知らせ • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.お知らせ • Dec 19+ 1 more updateFingertango Inc. Announces Resignation of Liu Jie as CEOThe board of directors of FingerTango Inc. announced that Mr. Liu Jie has tendered his resignation as chief executive officer of the Company, all with effect from 16 December 2024, due to his other business commitments.お知らせ • Dec 05FingeTtango Inc. Appoints Li Nini as an Executive DirectorThe board (the "Board") of directors (the "Directors" each a "Director") of FingerTango Inc. announce that, Ms. Li Nini ("Ms. Li") has been appointed as an executive Director of the Company with effect from 5 December 2024. The biographical details of Ms. Li are set out below: Ms. Li Nin, aged 42, join the Group on 3 December 2013. Ms. Li is vice president of the Group, mainly responsible for the business operation and project management. She has served as vice president of Shanghai Youmin Networks Technology Limited, a subsidiary of the Company, since December 2013. She is also the director of certain subsidiaries of the Group. Prior to joining the Group, she has worked with the founders of the Group. Ms. Li has over 10 years of experience in online game operation and management. Ms. Li graduated from Guangdong Ocean University with a bachelor degree in food science and engineering in June 2006 and graduated from Guangdong University of Technology with a master degree in food science in June 2009.お知らせ • Aug 16FingerTango Inc. to Report First Half, 2024 Results on Aug 28, 2024FingerTango Inc. announced that they will report first half, 2024 results on Aug 28, 2024お知らせ • Mar 29FingerTango Inc., Annual General Meeting, Jun 21, 2024FingerTango Inc., Annual General Meeting, Jun 21, 2024.お知らせ • Mar 19FingerTango Inc. to Report Fiscal Year 2023 Results on Mar 28, 2024FingerTango Inc. announced that they will report fiscal year 2023 results on Mar 28, 2024お知らせ • Aug 30FingerTango Inc. Announces Change of Independent Non-Executive Directors and Change in Composition of Board CommitteesThe board of directors of FingerTango Inc. announced that Dr. Liu Jianhua ("Dr. Liu") has tendered his resignation as an independent non-executive Director and the chairman of the audit committee of the Company (the "Audit Committee") with effect from 29 August 2023 due to his other businessengagement; and Mr. Guo Jingdou ("Mr. Guo") has tendered his resignation as an independentnon-executive Director and the chairman of the remuneration committee (the"Remuneration Committee"), a member of each of the Audit Committee andnomination committee of the Company (the "Nomination Committee") with effectfrom 29 August 2023 due to his other business engagement. The Board announce that Mr. Chow Wing Yiu ("Mr. Chow") has been appointed as an independentnon-executive Director and the chairman of the Audit Committee with effect from 29August 2023; and Mr. Shin Ho Chuen ("Mr. Shin") has been appointed as an independent non-executiveDirector and a member of each of the Audit Committee, the Remuneration Committeeand the Nomination Committee with effect from 29 August 2023.お知らせ • Aug 22FingerTango Inc. to Report First Half, 2023 Results on Aug 31, 2023FingerTango Inc. announced that they will report first half, 2023 results on Aug 31, 2023お知らせ • Jul 23+ 1 more updateFingerTango Inc. Announces Appointment of Ho Kim Fung as Chief Financial OfficerThe board of directors of FingerTango Inc. announced that Mr. Ho Kim Fung ("Mr. Ho") has been appointed as chief financial officer of the Company with effect from 21 July 2023. Mr. Ho, aged 35, has over 9 years of working experience in accounting, auditing, and financial management. For his working experience, Mr. Ho had served as an auditor in several professional firms of Certified Public Accountants in Hong Kong. Since 2017, Mr. Ho provides accounting and financial management services in several listed companies in Hong Kong. Between 2018 to 2019, Mr. Ho was appointed as an independent non-executive director and concurrently as the chairman of audit committee and risk management committee of a listed company in Hong Kong. Mr. Ho is currently the company secretary of a company listed on the main board of the Stock Exchange since 16 May 2019. Mr. Ho holds a degree of Bachelor of Business Administration in Accounting from Hong Kong Metropolitan University. For the aspect of professional qualifications, Mr. Ho is a member of Hong Kong Institute of Certified Public Accountants, a member of the Association of Chartered Certified Accountants, a member of CPA Australia, an associate member of Chartered Institute of Management Accountants and a designation holder of The Chartered Global Management Accountant.お知らせ • Jun 30FingerTango Inc. Announces Management ChangesThe board of directors of FingerTango Inc. announced that, Dr. Chan Man Fung ("Dr. Chan") has been appointed as an executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee") with effect from 29 June 2023. Dr. Chan, aged 36, received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan also is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for types 1 (dealing in securities), 2 (dealing in future contracts), 4 (advising on securities) and 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and currently is the substantial shareholder of a corporation licensed by the Securities and Futures Commission (the "SFC") to carry out types 1 (dealing in securities), 4 (advising on securities) and 9 (asset management) regulated activities under the SFO. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China (the "PRC"). Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the PRC and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that, Mr. Sui Pengda ("Mr. Sui") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee of the Company (the "Audit Committee"), Remuneration Committee and nomination committee of the Company (the "Nomination Committee") with effect from 29 June 2023 due to his other business engagement. The Board announced that Mr. Jiang Huihui ("Mr. Jiang") has been appointed as an independent non-executive Director and a member of each of the Audit Committee, Remuneration Committee and Nomination Committee with effect from 29 June 2023. Mr. Jiang, aged 39, obtained a bachelor degree of Engineering from University of Central Lancashire in 2005 and a degree of Master of Engineering Studies from University of Technology, Sydney in 2007. Mr. Jiang has extensive experience in finance, investment fund management and the media and entertainment related businesses. Mr. Jiang is currently the general manager of an assets management company located in Beijing, the PRC, responsible for the management of overall operation of the company. Mr. Jiang is also the management consultant of a film and television production company located in Beijing, the PRC, responsible for identifying issues in the company and developing plans of action for enhancing performance. Following the above mentioned resignation and appointment, the composition of the Board committees has changed with effect from 29 June 2023 as follows: Dr. Chan has been appointed as a member of the Remuneration Committee; Mr. Sui has ceased to be a member of each of the Audit Committee, Remuneration Committee and Nomination Committee; and Mr. Jiang has been appointed as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee. The Board announced that Mr. Liu Jie ("Mr. Liu") has ceased to be an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Listing Rules with effect from 29 June 2023. The Board announced that Dr. Chan Man Fung has been appointed as the Authorised Representative in replacement of Mr. Liu with effect from 29 June 2023.お知らせ • Jun 24FingerTango Inc. Announces Resignation of Zhu Yanbin as an Executive Director and A Member of Remuneration CommitteeThe board of directors of FingerTango Inc. announced that Mr. Zhu Yanbin (Mr. Zhu) has tendered his resignation as an executive director and a member of remuneration committee of the company with effect from 23 June 2023 due to his other business engagement.株主還元FGRT.FUS EntertainmentUS 市場7D0%2.5%1.0%1Y-77.6%-10.4%28.7%株主還元を見る業界別リターン: FGRT.F過去 1 年間で-10.4 % の収益を上げたUS Entertainment業界を下回りました。リターン対市場: FGRT.Fは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is FGRT.F's price volatile compared to industry and market?FGRT.F volatilityFGRT.F Average Weekly Movementn/aEntertainment Industry Average Movement9.0%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: FGRT.F 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 過去 1 年間のFGRT.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト2013347Jie Liuwww.fingertango.comもっと見るFingerTango Inc. 基礎のまとめFingerTango の収益と売上を時価総額と比較するとどうか。FGRT.F 基礎統計学時価総額US$19.68m収益（TTM）-US$13.55m売上高(TTM)US$105.40m0.2xP/Sレシオ-1.4xPER（株価収益率FGRT.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計FGRT.F 損益計算書（TTM）収益CN¥752.34m売上原価CN¥293.39m売上総利益CN¥458.95mその他の費用CN¥555.65m収益-CN¥96.71m直近の収益報告Jun 30, 2023次回決算日該当なし一株当たり利益（EPS）-0.05グロス・マージン61.00%純利益率-12.85%有利子負債／自己資本比率0%FGRT.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/12/19 18:49終値2023/09/21 00:00収益2023/06/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FingerTango Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.
お知らせ • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026
お知らせ • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.
お知らせ • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025
お知らせ • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.
お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.
お知らせ • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026
お知らせ • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.
お知らせ • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025
お知らせ • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.
お知らせ • Dec 19+ 1 more updateFingertango Inc. Announces Resignation of Liu Jie as CEOThe board of directors of FingerTango Inc. announced that Mr. Liu Jie has tendered his resignation as chief executive officer of the Company, all with effect from 16 December 2024, due to his other business commitments.
お知らせ • Dec 05FingeTtango Inc. Appoints Li Nini as an Executive DirectorThe board (the "Board") of directors (the "Directors" each a "Director") of FingerTango Inc. announce that, Ms. Li Nini ("Ms. Li") has been appointed as an executive Director of the Company with effect from 5 December 2024. The biographical details of Ms. Li are set out below: Ms. Li Nin, aged 42, join the Group on 3 December 2013. Ms. Li is vice president of the Group, mainly responsible for the business operation and project management. She has served as vice president of Shanghai Youmin Networks Technology Limited, a subsidiary of the Company, since December 2013. She is also the director of certain subsidiaries of the Group. Prior to joining the Group, she has worked with the founders of the Group. Ms. Li has over 10 years of experience in online game operation and management. Ms. Li graduated from Guangdong Ocean University with a bachelor degree in food science and engineering in June 2006 and graduated from Guangdong University of Technology with a master degree in food science in June 2009.
お知らせ • Aug 16FingerTango Inc. to Report First Half, 2024 Results on Aug 28, 2024FingerTango Inc. announced that they will report first half, 2024 results on Aug 28, 2024
お知らせ • Mar 29FingerTango Inc., Annual General Meeting, Jun 21, 2024FingerTango Inc., Annual General Meeting, Jun 21, 2024.
お知らせ • Mar 19FingerTango Inc. to Report Fiscal Year 2023 Results on Mar 28, 2024FingerTango Inc. announced that they will report fiscal year 2023 results on Mar 28, 2024
お知らせ • Aug 30FingerTango Inc. Announces Change of Independent Non-Executive Directors and Change in Composition of Board CommitteesThe board of directors of FingerTango Inc. announced that Dr. Liu Jianhua ("Dr. Liu") has tendered his resignation as an independent non-executive Director and the chairman of the audit committee of the Company (the "Audit Committee") with effect from 29 August 2023 due to his other businessengagement; and Mr. Guo Jingdou ("Mr. Guo") has tendered his resignation as an independentnon-executive Director and the chairman of the remuneration committee (the"Remuneration Committee"), a member of each of the Audit Committee andnomination committee of the Company (the "Nomination Committee") with effectfrom 29 August 2023 due to his other business engagement. The Board announce that Mr. Chow Wing Yiu ("Mr. Chow") has been appointed as an independentnon-executive Director and the chairman of the Audit Committee with effect from 29August 2023; and Mr. Shin Ho Chuen ("Mr. Shin") has been appointed as an independent non-executiveDirector and a member of each of the Audit Committee, the Remuneration Committeeand the Nomination Committee with effect from 29 August 2023.
お知らせ • Aug 22FingerTango Inc. to Report First Half, 2023 Results on Aug 31, 2023FingerTango Inc. announced that they will report first half, 2023 results on Aug 31, 2023
お知らせ • Jul 23+ 1 more updateFingerTango Inc. Announces Appointment of Ho Kim Fung as Chief Financial OfficerThe board of directors of FingerTango Inc. announced that Mr. Ho Kim Fung ("Mr. Ho") has been appointed as chief financial officer of the Company with effect from 21 July 2023. Mr. Ho, aged 35, has over 9 years of working experience in accounting, auditing, and financial management. For his working experience, Mr. Ho had served as an auditor in several professional firms of Certified Public Accountants in Hong Kong. Since 2017, Mr. Ho provides accounting and financial management services in several listed companies in Hong Kong. Between 2018 to 2019, Mr. Ho was appointed as an independent non-executive director and concurrently as the chairman of audit committee and risk management committee of a listed company in Hong Kong. Mr. Ho is currently the company secretary of a company listed on the main board of the Stock Exchange since 16 May 2019. Mr. Ho holds a degree of Bachelor of Business Administration in Accounting from Hong Kong Metropolitan University. For the aspect of professional qualifications, Mr. Ho is a member of Hong Kong Institute of Certified Public Accountants, a member of the Association of Chartered Certified Accountants, a member of CPA Australia, an associate member of Chartered Institute of Management Accountants and a designation holder of The Chartered Global Management Accountant.
お知らせ • Jun 30FingerTango Inc. Announces Management ChangesThe board of directors of FingerTango Inc. announced that, Dr. Chan Man Fung ("Dr. Chan") has been appointed as an executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee") with effect from 29 June 2023. Dr. Chan, aged 36, received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan also is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for types 1 (dealing in securities), 2 (dealing in future contracts), 4 (advising on securities) and 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and currently is the substantial shareholder of a corporation licensed by the Securities and Futures Commission (the "SFC") to carry out types 1 (dealing in securities), 4 (advising on securities) and 9 (asset management) regulated activities under the SFO. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China (the "PRC"). Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the PRC and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that, Mr. Sui Pengda ("Mr. Sui") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee of the Company (the "Audit Committee"), Remuneration Committee and nomination committee of the Company (the "Nomination Committee") with effect from 29 June 2023 due to his other business engagement. The Board announced that Mr. Jiang Huihui ("Mr. Jiang") has been appointed as an independent non-executive Director and a member of each of the Audit Committee, Remuneration Committee and Nomination Committee with effect from 29 June 2023. Mr. Jiang, aged 39, obtained a bachelor degree of Engineering from University of Central Lancashire in 2005 and a degree of Master of Engineering Studies from University of Technology, Sydney in 2007. Mr. Jiang has extensive experience in finance, investment fund management and the media and entertainment related businesses. Mr. Jiang is currently the general manager of an assets management company located in Beijing, the PRC, responsible for the management of overall operation of the company. Mr. Jiang is also the management consultant of a film and television production company located in Beijing, the PRC, responsible for identifying issues in the company and developing plans of action for enhancing performance. Following the above mentioned resignation and appointment, the composition of the Board committees has changed with effect from 29 June 2023 as follows: Dr. Chan has been appointed as a member of the Remuneration Committee; Mr. Sui has ceased to be a member of each of the Audit Committee, Remuneration Committee and Nomination Committee; and Mr. Jiang has been appointed as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee. The Board announced that Mr. Liu Jie ("Mr. Liu") has ceased to be an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Listing Rules with effect from 29 June 2023. The Board announced that Dr. Chan Man Fung has been appointed as the Authorised Representative in replacement of Mr. Liu with effect from 29 June 2023.
お知らせ • Jun 24FingerTango Inc. Announces Resignation of Zhu Yanbin as an Executive Director and A Member of Remuneration CommitteeThe board of directors of FingerTango Inc. announced that Mr. Zhu Yanbin (Mr. Zhu) has tendered his resignation as an executive director and a member of remuneration committee of the company with effect from 23 June 2023 due to his other business engagement.
